文献速递主动脉疾病

应用开窗支架腔内装置挽救失败的主动脉修复

Rescue of Failed Aortic Repair with Fenestrated Endovascular Device.
PubMed 文献 · Ann Vasc Surg · 2021-12-10

单中心前瞻性数据库研究纳入2011年1月1日至2019年3月31日间17例因既往EVAR或开放手术后失败而植入ZFEN开窗支架行挽救性修复的患者,主要技术成功率70.5%,30天再干预率23.5%,围术期无死亡,1年总生存率92%。作者认为FEVAR是挽救失败主动脉修复安全但技术具有挑战性的选择。

要点

  • 17例失败主动脉修复患者接受ZFEN开窗支架挽救,主要技术成功率70.5%。
  • 围术期部署相关并发症5.8%,全身并发症35%,30天再干预率23.5%。
  • 研究随访期内无死亡,1年总生存率92%。

核心结论

  • 作者认为FEVAR是挽救失败主动脉修复安全但技术具有挑战性的选择。
  • 作者指出该组为高风险患者,反映为术后高并发症率。
  • 作者指出技术成功率高且30天死亡率低。

研究设计与样本

  • 单中心经验,查询前瞻性维护的ZFEN开窗支架腔内修复患者数据库。
  • 纳入既往EVAR或开放修复后作为挽救治疗植入ZFEN装置的患者。
  • 2011年1月1日至2019年3月31日间共植入17例ZFEN装置。
  • 10例为既往EVAR后1a型内漏,7例为既往开放修复后近端病变进展。
  • 12例男性、5例女性,中位年龄75岁(四分位距7)。

主要发现

  • 主要技术成功率为70.5%(n=12)。
  • 其余病例中4例(24%)在完成造影时存在III型内漏,其中2例(12%)在30天内需要再干预。
  • 另1例(6%)因需对髂血管限流性夹层瓣膜置入支架而达到主要辅助技术成功。
  • 围术期部署相关并发症发生率为5.8%(n=1),全身并发症发生率为35%(n=6)。
  • 中位住院时间为11天(四分位距11),研究随访期内无死亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The incidence of failed endovascular (EVAR) and open repair (OR) is increasing. Redo aortic repair is required in 10% of patients. Extension of the proximal sealing zone above the visceral arteries to adequate, healthier thoracic aorta using a fenestrated graft (FEVAR) can rescue a failing repair. A custom-made device can treat proximal type 1a endoleaks or proximal dilatation post endovascular or open repair, respectively. The aim of this investigation was to present a single-centre experience with FEVAR for patients with a failing aortic repair. METHODS: A prospectively maintained database of FEVAR patients treated with a ZenithⓇ Fenestrated endovascular (ZFEN) device (Cook Medical LLC, Bloomington, Indiana, USA) was interrogated for individuals who had the device implanted as a rescue therapy after prior endovascular (EVAR) or open repair (OR). Statistical analysis was performed with SPSS v 25 software. RESULTS: Between January 1, 2011 and March 31, 2019, 17 ZFEN devices were implanted. 10 patients had a type 1a endoleak from a prior EVAR and 7 patients had proximal disease progression after prior OR. There were 12 males and 5 females, median age of 75 (interquartile range, IQR 7). 76.4% (n = 13) of patients had an American Society of Anaesthesiologists (ASA) grade of 3. Primary technical success was 70.5% (n = 12). Of the remainder, 4 cases (24%) had a type III endoleak at completion angiogram; of which, 2 patients (12%) required re-intervention within 30 days. One further case (6%) had primary assisted technical success as stenting of a flow limiting dissection flap in an iliac vessel was required. Peri-operative rate of deployment related complications and systemic complications were 5.8% (n = 1) and 35% (n = 6), respectively. Median length of hospital stay was 11 days (IQR 11). There was no mortality within the study follow up. Overall 30-day re-intervention rate was 23.5%. Overall survival was 92% at one year. CONCLUSION: FEVAR is a safe but technically challenging option for rescue of failing aortic repairs. These are a high-risk group of patients and this is reflected in the high post-operative morbidity rate. Technical success was high and 30-day mortality was low.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kiernan A, Elsherif M, Fahey B, et al. Rescue of Failed Aortic Repair with Fenestrated Endovascular Device. Ann Vasc Surg. 2021. PMID: 34902472. doi:10.1016/j.avsg.2021.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。